Genzyme Corporation recalls Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg…
- Recall date
- October 12, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0075-2018
- FDA classification
- Class III
- Brand / firm
- Genzyme Corporation
- Sold / distributed
- Nationwide
Why it was recalled
Labeling: Incorrect or Missing Package Insert.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg 5 Haarlem, The Netherlands Mfd. for: Genzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01.
Get recall alerts
Free email alert whenever Genzyme Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Genzyme Corporation